HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target

HC Wainwright & Co. analyst Brandon Folkes has reiterated a 'Buy' rating on Connect Biopharma Holdings (NASDAQ: CNTB) and maintained a price target of $7 for the stock. No additional financial figures or strategic changes were mentioned in the article.